99365-48-7Relevant academic research and scientific papers
NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS
-
Paragraph 0140; 0141, (2019/11/29)
This invention relates to certain novel pyrazine derivatives (Formula I) as SHP2 inhibitors which is shown as formula I, their synthesis and their use for treating a SHP2 mediated disorder. More particularly, this invention is directed to fused heterocycl
NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS
-
Page/Page column 42, (2018/01/19)
Provided are certain pyrazine derivatives (I) as SHP2 inhibitors which is shown as formula (I), their synthesis and their use for treating a SHP2 mediated disorder. More particularly, provided are fused heterocyclic derivatives useful as inhibitors of SHP
Selective reduction of carbonyl groups in the presence of low-valent titanium reagents
Lin, Wei,Hu, Ming-Hua,Feng, Xian,Fu, Lei,Cao, Cheng-Pao,Huang, Zhi-Bin,Shi, Da-Qing
, p. 2238 - 2242 (2014/04/17)
The chemoselective reduction of several structurally diverse compounds containing carbonyl groups was achieved in the presence of low-valent titanium reagents. This novel synthetic method provides easy access to highly selective reduction of carbonyl groups, and possesses several advantages including one-step procedure, convenient manipulation, good to excellent yields, and short reaction times.
Synthesis of the bicyclic welwitindolinone core via an alkylation/ cyclization cascade reaction
Brailsford, John A.,Lauchli, Ryan,Shea, Kenneth J.
supporting information; experimental part, p. 5330 - 5333 (2010/02/28)
Synthesis of an advanced welwitindolinone intermediate via an alkylation/cyclization reaction is reported. The key step involves a one pot Lewis acid-mediated alkylation of a silylketene aminal with a furan alcohol followed by an intramolecular cyclizatio
TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS
-
Page 258, (2008/06/13)
The present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation comprising administering to a patient in need thereof an effective amount of a compound of the formula (I): or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula (I), including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula (I).
Heterocyclic sulfonamide derivatives
-
Page 16, (2010/11/29)
The present invention provides certain heterocyclic sulfonamide derivatives of formula (I): useful for potentiating glutamate receptor function in a patient and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.
Synthesis and some reactions of 6-bromooxindole
Kosuge,Ishida,Inaba,Nukaya
, p. 1414 - 1418 (2007/10/02)
An efficient synthesis of 4- and 6-bromooxindoles, previously unknown compounds, from 6- and 4-amino-2-nitrotoluenes and the transformation of 6-bromooxindole to 3-acylated derivatives are described.
